Franklin Resources’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4M | Buy |
2,543,539
+1,540
| +0.1% | +$20.2K | 0.01% | 756 |
|
|
2025
Q1 | $36.6M | Buy |
2,541,999
+233,453
| +10% | +$3.36M | 0.01% | 709 |
|
|
2024
Q4 | $38.7M | Buy |
2,308,546
+6,000
| +0.3% | +$101K | 0.01% | 695 |
|
|
2024
Q3 | $38.4M | Buy |
2,302,546
+1,145,823
| +99% | +$19.1M | 0.01% | 685 |
|
|
2024
Q2 | $10.4M | Hold |
1,156,723
| – | – | ﹤0.01% | 1062 |
|
|
2024
Q1 | $13.1M | Buy |
1,156,723
+40,906
| +4% | +$462K | ﹤0.01% | 991 |
|
|
2023
Q4 | $8.88M | Buy |
1,115,817
+283,469
| +34% | +$2.26M | ﹤0.01% | 960 |
|
|
2023
Q3 | $5.39M | Hold |
832,348
| – | – | ﹤0.01% | 1069 |
|
|
2023
Q2 | $5.15M | Hold |
832,348
| – | – | ﹤0.01% | 1106 |
|
|
2023
Q1 | $3.2M | Hold |
832,348
| – | – | ﹤0.01% | 1231 |
|
|
2022
Q4 | $2.58M | Sell |
832,348
-584
| -0.1% | -$1.81K | ﹤0.01% | 1302 |
|
|
2022
Q3 | $3.35M | Hold |
832,932
| – | – | ﹤0.01% | 1191 |
|
|
2022
Q2 | $4.06M | Buy |
832,932
+216,029
| +35% | +$1.05M | ﹤0.01% | 1157 |
|
|
2022
Q1 | $5.53M | Buy |
616,903
+41,365
| +7% | +$371K | ﹤0.01% | 1144 |
|
|
2021
Q4 | $6.48M | Sell |
575,538
-346,562
| -38% | -$3.9M | ﹤0.01% | 1162 |
|
|
2021
Q3 | $15.4M | Sell |
922,100
-600
| -0.1% | -$10K | 0.01% | 951 |
|
|
2021
Q2 | $20.5M | Buy |
+922,700
| New | +$20.5M | 0.01% | 849 |
|